EMEA (Europe, Middle East and Africa) Human Endostatin Market Report 2017

December 2017 | 104 pages | ID: EC2F42A8AF1EN
QYResearch

Abstracts

In this report, the EMEA Human Endostatin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Human Endostatin for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Endostatin market competition by top manufacturers/players, with Human Endostatin sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Thermo Fisher Scientific
• ELISA

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Purity:95%
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Medical Care
• Scientific Research
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Human Endostatin Market Report 2017

1 HUMAN ENDOSTATIN OVERVIEW

1.1 Product Overview and Scope of Human Endostatin
1.2 Classification of Human Endostatin
  1.2.1 EMEA Human Endostatin Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Human Endostatin Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Purity:95%
  1.2.4 Others
1.3 EMEA Human Endostatin Market by Application/End Users
  1.3.1 EMEA Human Endostatin Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Medical Care
  1.3.3 Scientific Research
  1.3.4 Others
1.4 EMEA Human Endostatin Market by Region
  1.4.1 EMEA Human Endostatin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Human Endostatin (2012-2022)
  1.5.1 EMEA Human Endostatin Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Human Endostatin Revenue and Growth Rate (2012-2022)

2 EMEA HUMAN ENDOSTATIN COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Human Endostatin Market Competition by Players/Manufacturers
  2.1.1 EMEA Human Endostatin Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Human Endostatin Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Human Endostatin Sale Price by Players (2012-2017)
2.2 EMEA Human Endostatin (Volume and Value) by Type/Product Category
  2.2.1 EMEA Human Endostatin Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Human Endostatin Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Human Endostatin Sale Price by Type (2012-2017)
2.3 EMEA Human Endostatin (Volume) by Application
2.4 EMEA Human Endostatin (Volume and Value) by Region
  2.4.1 EMEA Human Endostatin Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Human Endostatin Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Human Endostatin Sales Price by Region (2012-2017)

3 EUROPE HUMAN ENDOSTATIN (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Human Endostatin Sales and Value (2012-2017)
  3.1.1 Europe Human Endostatin Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Human Endostatin Revenue and Growth Rate (2012-2017)
3.2 Europe Human Endostatin Sales and Market Share by Type
3.3 Europe Human Endostatin Sales and Market Share by Application
3.4 Europe Human Endostatin Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Human Endostatin Sales Volume by Countries (2012-2017)
  3.4.2 Europe Human Endostatin Revenue by Countries (2012-2017)
  3.4.3 Germany Human Endostatin Sales and Growth Rate (2012-2017)
  3.4.4 France Human Endostatin Sales and Growth Rate (2012-2017)
  3.4.5 UK Human Endostatin Sales and Growth Rate (2012-2017)
  3.4.6 Russia Human Endostatin Sales and Growth Rate (2012-2017)
  3.4.7 Italy Human Endostatin Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Human Endostatin Sales and Growth Rate (2012-2017)

4 MIDDLE EAST HUMAN ENDOSTATIN (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Human Endostatin Sales and Value (2012-2017)
  4.1.1 Middle East Human Endostatin Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Human Endostatin Revenue and Growth Rate (2012-2017)
4.2 Middle East Human Endostatin Sales and Market Share by Type
4.3 Middle East Human Endostatin Sales and Market Share by Application
4.4 Middle East Human Endostatin Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Human Endostatin Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Human Endostatin Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Human Endostatin Sales and Growth Rate (2012-2017)
  4.4.4 Israel Human Endostatin Sales and Growth Rate (2012-2017)
  4.4.5 UAE Human Endostatin Sales and Growth Rate (2012-2017)
  4.4.6 Iran Human Endostatin Sales and Growth Rate (2012-2017)

5 AFRICA HUMAN ENDOSTATIN (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Human Endostatin Sales and Value (2012-2017)
  5.1.1 Africa Human Endostatin Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Human Endostatin Revenue and Growth Rate (2012-2017)
5.2 Africa Human Endostatin Sales and Market Share by Type
5.3 Africa Human Endostatin Sales and Market Share by Application
5.4 Africa Human Endostatin Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Human Endostatin Sales Volume by Countries (2012-2017)
  5.4.2 Africa Human Endostatin Revenue by Countries (2012-2017)
  5.4.3 South Africa Human Endostatin Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Human Endostatin Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Human Endostatin Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Human Endostatin Sales and Growth Rate (2012-2017)

6 EMEA HUMAN ENDOSTATIN MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Thermo Fisher Scientific
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Endostatin Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Thermo Fisher Scientific Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 ELISA
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Human Endostatin Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 ELISA Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview

7 HUMAN ENDOSTATIN MANUFACTURING COST ANALYSIS

7.1 Human Endostatin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Endostatin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Endostatin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Endostatin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HUMAN ENDOSTATIN MARKET FORECAST (2017-2022)

11.1 EMEA Human Endostatin Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Human Endostatin Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Human Endostatin Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Human Endostatin Price and Trend Forecast (2017-2022)
11.2 EMEA Human Endostatin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Human Endostatin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Human Endostatin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Human Endostatin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Human Endostatin Sales Forecast by Type (2017-2022)
11.7 EMEA Human Endostatin Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Endostatin
Figure EMEA Human Endostatin Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Human Endostatin Sales Volume Market Share by Type (Product Category) in 2016
Figure Purity:95% Product Picture
Figure Others Product Picture
Figure EMEA Human Endostatin Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Human Endostatin by Application in 2016
Figure Medical Care Examples
Table Key Downstream Customer in Medical Care
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Human Endostatin Market Size (Million USD) by Region (2012-2022)
Figure Europe Human Endostatin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Human Endostatin Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Human Endostatin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Human Endostatin Revenue (Million USD) Status and Forecast by Countries
Figure Africa Human Endostatin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Human Endostatin Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Human Endostatin Sales Volume and Growth Rate (2012-2022)
Figure EMEA Human Endostatin Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Human Endostatin Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Human Endostatin Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Human Endostatin Sales Share by Players (2012-2017)
Figure 2016 Human Endostatin Sales Share by Players
Figure 2017 Human Endostatin Sales Share by Players
Figure EMEA Human Endostatin Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Human Endostatin Revenue (Million USD) by Players (2012-2017)
Table EMEA Human Endostatin Revenue Share by Players (2012-2017)
Table 2016 EMEA Human Endostatin Revenue Share by Players
Table 2017 EMEA Human Endostatin Revenue Share by Players
Table EMEA Human Endostatin Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Human Endostatin Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Human Endostatin Sales Share by Type (2012-2017)
Figure Sales Market Share of Human Endostatin by Type (2012-2017)
Figure EMEA Human Endostatin Sales Market Share by Type (2012-2017)
Table EMEA Human Endostatin Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Human Endostatin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Endostatin by Type in 2016
Table EMEA Human Endostatin Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Human Endostatin Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Human Endostatin Sales Share by Application (2012-2017)
Figure Sales Market Share of Human Endostatin by Application (2012-2017)
Figure EMEA Human Endostatin Sales Market Share by Application in 2016
Table EMEA Human Endostatin Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Human Endostatin Sales Share by Region (2012-2017)
Figure Sales Market Share of Human Endostatin by Region (2012-2017)
Figure EMEA Human Endostatin Sales Market Share in 2016
Table EMEA Human Endostatin Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Human Endostatin Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Human Endostatin by Region (2012-2017)
Figure EMEA Human Endostatin Revenue Market Share Regions in 2016
Table EMEA Human Endostatin Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Human Endostatin Revenue and Growth Rate (2012-2017)
Table Europe Human Endostatin Sales (K Pcs) by Type (2012-2017)
Table Europe Human Endostatin Market Share by Type (2012-2017)
Figure Europe Human Endostatin Market Share by Type in 2016
Table Europe Human Endostatin Sales (K Pcs) by Application (2012-2017)
Table Europe Human Endostatin Market Share by Application (2012-2017)
Figure Europe Human Endostatin Market Share by Application in 2016
Table Europe Human Endostatin Sales (K Pcs) by Countries (2012-2017)
Table Europe Human Endostatin Sales Market Share by Countries (2012-2017)
Figure Europe Human Endostatin Sales Market Share by Countries (2012-2017)
Figure Europe Human Endostatin Sales Market Share by Countries in 2016
Table Europe Human Endostatin Revenue (Million USD) by Countries (2012-2017)
Table Europe Human Endostatin Revenue Market Share by Countries (2012-2017)
Figure Europe Human Endostatin Revenue Market Share by Countries (2012-2017)
Figure Europe Human Endostatin Revenue Market Share by Countries in 2016
Figure Germany Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Human Endostatin Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Human Endostatin Sales (K Pcs) by Type (2012-2017)
Table Middle East Human Endostatin Market Share by Type (2012-2017)
Figure Middle East Human Endostatin Market Share by Type (2012-2017)
Table Middle East Human Endostatin Sales (K Pcs) by Applications (2012-2017)
Table Middle East Human Endostatin Market Share by Applications (2012-2017)
Figure Middle East Human Endostatin Sales Market Share by Application in 2016
Table Middle East Human Endostatin Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Human Endostatin Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Human Endostatin Sales Volume Market Share by Countries in 2016
Table Middle East Human Endostatin Revenue (Million USD) by Countries (2012-2017)
Table Middle East Human Endostatin Revenue Market Share by Countries (2012-2017)
Figure Middle East Human Endostatin Revenue Market Share by Countries (2012-2017)
Figure Middle East Human Endostatin Revenue Market Share by Countries in 2016
Figure Saudi Arabia Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Human Endostatin Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Human Endostatin Sales (K Pcs) by Type (2012-2017)
Table Africa Human Endostatin Sales Market Share by Type (2012-2017)
Figure Africa Human Endostatin Sales Market Share by Type (2012-2017)
Figure Africa Human Endostatin Sales Market Share by Type in 2016
Table Africa Human Endostatin Sales (K Pcs) by Application (2012-2017)
Table Africa Human Endostatin Sales Market Share by Application (2012-2017)
Figure Africa Human Endostatin Sales Market Share by Application (2012-2017)
Table Africa Human Endostatin Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Human Endostatin Sales Market Share by Countries (2012-2017)
Figure Africa Human Endostatin Sales Market Share by Countries (2012-2017)
Figure Africa Human Endostatin Sales Market Share by Countries in 2016
Table Africa Human Endostatin Revenue (Million USD) by Countries (2012-2017)
Table Africa Human Endostatin Revenue Market Share by Countries (2012-2017)
Figure Africa Human Endostatin Revenue Market Share by Countries (2012-2017)
Figure Africa Human Endostatin Revenue Market Share by Countries in 2016
Figure South Africa Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Table Thermo Fisher Scientific Human Endostatin Basic Information List
Table Thermo Fisher Scientific Human Endostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Human Endostatin Sales Market Share in EMEA (2012-2017)
Figure Thermo Fisher Scientific Human Endostatin Revenue Market Share in EMEA (2012-2017)
Table ELISA Human Endostatin Basic Information List
Table ELISA Human Endostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ELISA Human Endostatin Sales (K Pcs) and Growth Rate (2012-2017)
Figure ELISA Human Endostatin Sales Market Share in EMEA (2012-2017)
Figure ELISA Human Endostatin Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Endostatin
Figure Manufacturing Process Analysis of Human Endostatin
Figure Human Endostatin Industrial Chain Analysis
Table Raw Materials Sources of Human Endostatin Major Manufacturers in 2016
Table Major Buyers of Human Endostatin
Table Distributors/Traders List
Figure EMEA Human Endostatin Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Human Endostatin Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Human Endostatin Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Human Endostatin Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Human Endostatin Sales Market Share Forecast by Region (2017-2022)
Table EMEA Human Endostatin Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Human Endostatin Revenue Market Share Forecast by Region (2017-2022)
Table Europe Human Endostatin Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Human Endostatin Sales Market Share Forecast by Countries (2017-2022)
Table Europe Human Endostatin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Human Endostatin Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Human Endostatin Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Human Endostatin Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Human Endostatin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Human Endostatin Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Human Endostatin Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Human Endostatin Sales Market Share Forecast by Countries (2017-2022)
Table Africa Human Endostatin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Human Endostatin Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Human Endostatin Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Human Endostatin Sales Market Share Forecast by Type (2017-2022)
Table EMEA Human Endostatin Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Human Endostatin Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources